SN BioScience and Boryung Announce the Licensing Agreement on Generic Version of Abraxane ...Middle East

First Generic of Abraxane in Korea, World 4th Commercial Scale-Up Global tech-transfer expected to US, Japan, and Europe SEONGNAM, South Korea, Jan. 26, 2023 /PRNewswire/ -- SN BioScience (CEO Park Young-hwan) and Boryeong (CEO Jang Doo-hyun) signed a domestic manufacturing technology...

Hence then, the article about sn bioscience and boryung announce the licensing agreement on generic version of abraxane was published today ( Thursday 26/01/2023 - 09:56 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( SN BioScience and Boryung Announce the Licensing Agreement on Generic Version of Abraxane )

Also on site :

• Today’s NYT ‘Strands’ Hints, Spangram and Answers for Saturday, January 17, 2026
• Maison Margiela’s 'Elegant' Duo Perfume Set Makes Fragrance Layering Easy, and It’s Just $30 at Kohl’s 
• Royal Caribbean Extends Pause at Private Caribbean Resort Through 2026—Here’s What Cruisers Are Getting Instead